Wang et al.'s study suggested that lncRNA ANRIL overexpression was significantly associated with lymph node metastases, TNM stage, and poor prognosis and revealed that lncRNA ANRIL may serve as a novel biomarker for lymph node metastases and disease prediction. The gene discussed is CDKN2B-AS1; the disease is metastatic malignant neoplasm in the lymph nodes.